These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does sulphinpyrazone prevent recurrence of myocardial infarction? Lancet; 1982 Mar; 1(8274):735-6. PubMed ID: 6122022 [No Abstract] [Full Text] [Related]
3. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. Anturane Reinfarction Trial Research Group N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942 [TBL] [Abstract][Full Text] [Related]
4. Sulphinpyrazone (Anturan) after myocardial infarct. Watt M N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352 [No Abstract] [Full Text] [Related]
5. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. Anturane Reinfarction Trial Research Group N Engl J Med; 1980 Jan; 302(5):250-6. PubMed ID: 6985706 [TBL] [Abstract][Full Text] [Related]
6. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients. Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008 [No Abstract] [Full Text] [Related]
7. Prevention of death from myocardial infarction by aspirin and other platelet active drugs. Elwood PC Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517 [No Abstract] [Full Text] [Related]
8. Aspirin and recurrent myocardial infarction. Jones RJ JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715 [No Abstract] [Full Text] [Related]
9. Sulfinpyrazone after myocardial infarction. N Engl J Med; 1978 Jun; 298(22):1257-9. PubMed ID: 349383 [No Abstract] [Full Text] [Related]
10. More on sulfinpyrazone after myocardial infarction. Hood WB N Engl J Med; 1982 Apr; 306(16):988-9. PubMed ID: 7038499 [No Abstract] [Full Text] [Related]
11. Secondary prevention of myocardial infarction--the present state of the ART. Mitchell JR Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236 [No Abstract] [Full Text] [Related]
13. Sulphinpyrazone and myocardial infarction. Tulloch JA; Marr TC Curr Med Res Opin; 1981; 7(7):440-2. PubMed ID: 7261661 [No Abstract] [Full Text] [Related]
14. The FDA's critique of the anturane reinfarction trial. Temple R; Pledger GW N Engl J Med; 1980 Dec; 303(25):1488-92. PubMed ID: 7432418 [No Abstract] [Full Text] [Related]
15. Sulfinpyrazone after myocardial infarction: no decision yet. Relman AS N Engl J Med; 1980 Dec; 303(25):1476-7. PubMed ID: 7432408 [No Abstract] [Full Text] [Related]
16. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
17. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction. Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218 [TBL] [Abstract][Full Text] [Related]